VoiceOver users please use the tab key when navigating expanded menus

ANZ increases allocation of ANZ Capital Notes 5 to $930 million; Broker Firm New Money Offer will not proceed

ANZ today announced that it will allocate approximately $930 million ANZ Capital Notes 5 under the ANZ Securityholder Offer and Broker Firm Reinvestment Offer which both closed on 13 September 2017.

All valid applications under the ANZ Securityholder Offer and the Broker Firm Reinvestment Offer have been accepted in full.


The amount to be allocated satisfies ANZ’s funding requirement and accordingly ANZ will not open the Broker Firm New Money Offer.


Applications under the CPS3 Buy-Back Facility


Eligible CPS3 Holders holding approximately $812 million of CPS3 applied to sell their CPS3 into the Buy-Back Facility. These holders elected to:

- reinvest in ANZ Capital Notes 5 approximately $682 million; and

- receive the sale proceeds in cash for approximately $130 million.


Approximately $528 million of CPS3 will remain on issue (until redeemed or converted at a future date in accordance with the CPS3 terms).


Approximately 8.12 million CPS3 with a face value of $100 each will be offered for sale on-market on 26 September 2017 by Morgan Stanley (acting as Selling Broker) under the Buy-Back Facility. Any amount purchased on-market on 26 September 2017 by UBS (acting as Buying Broker on behalf of ANZ) will cease trading on ASX and be cancelled on 28 September 2017.


Subject to settlement of the Buy-Back, Eligible CPS3 Holders who validly elected to sell their CPS3 under the Buy-Back Facility will be issued ANZ Capital Notes 5 or paid cash on 28 September 2017 (as applicable).


Payment of the Pro Rata Dividend


CPS3 holders on the Register on the record date of 20 September 2017 are also entitled to the Pro Rata Dividend of $0.2586 per CPS3 for the Dividend Period from (and including) 1 September 2017 to (but excluding) 28 September 2017, subject to the settlement of the Buy-Back and satisfaction of the conditions to payment set out in the CPS3 terms.


Capitalised terms in this announcement have the meaning given to them in the ANZ Capital Notes 5 Prospectus dated 24 August 2017.


For investor enquiries, please:

- view capitalnotes5.anz.com; or

- contact the ANZ Information Line on 1800 113 399 (Australia) or +61 3 9415 4010 (international) Monday to Friday – 8.30am –    5.30pm AET.


NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE U.S. This statement does not constitute an offer of any securities for sale. The securities offered will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.


View PDF